SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-17-012133
Filing Date
2017-10-27
Accepted
2017-10-27 17:14:07
Documents
12
Period of Report
2017-10-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 43082
2 ex1-1.htm EX-1.1 359288
3 ex5-1.htm EX-5.1 38276
4 ex5-2.htm EX-5.2 38530
5 ex5-3.htm EX-5.3 16678
6 ex10-1.htm EX-10.1 149712
7 ex99-1.htm EX-99.1 17021
8 ex5-1_001.jpg GRAPHIC 4179
9 ex5-1_002.jpg GRAPHIC 6556
10 ex5-2_001.jpg GRAPHIC 3755
11 ex5-2_002.jpg GRAPHIC 6218
12 ex99-1_001.jpg GRAPHIC 6231
  Complete submission text file 0001493152-17-012133.txt   701731
Mailing Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142
Business Address 222 THIRD STREET SUITE 2241 CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 171160162
SIC: 2834 Pharmaceutical Preparations